| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
| mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |